Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 17, 2008
Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virusCecilia T Costiniuk, Edward Mills, Curtis L Cooper
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 23, 2007
Barriers preventing liver transplantation in Canadians with HIV-infection--perceptions of HIV specialistsCurtis L Cooper, Joanne DeForest, John Gill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2002
Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virusCurtis L Cooper, M A Parbhakar, Jonathan B Angel
Annals of Hepatology|August 16, 2017
Hepatitis C Virus Infection Outcomes Among Immigrants to Canada: A Retrospective Cohort AnalysisCurtis L Cooper, Kednapa Thavorn, Ecaterina Damian, et al.
Patient Preference and Adherence|June 3, 2010
Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patientsJoel Emery, Neora Pick, Edward J Mills, et al.
European Journal of Gastroenterology & Hepatology|November 1, 2018
Direct-acting antiviral hepatitis C virus treatment perturbation of the metabolic milieuMatt Driedger, Chrissi Galanakis, Mary-Anne Doyle, et al.
Canadian Liver Journal|September 22, 2022
Uptake and factors associated with direct-acting antiviral therapy for hepatitis C and treatment outcomes among Canadian immigrants: A retrospective cohort analysisYelena Petrosyan, John-Graydon Simmons, Erin Kelly, et al.
Therapeutics and Clinical Risk Management|May 14, 2010
Equitable access to HCV care in HIV-HCV co-infection can be achieved despite barriers to health care provisionCurtis L Cooper, Celine Giordano, Dave Mackie, et al.
European Journal of Gastroenterology & Hepatology|April 13, 2012
Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatmentErin M Kelly, Kimberly Corace, Joel Emery, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|January 25, 2006
Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfectionC L Cooper, Curtis L Cooper, Paul MacPherson, et al.
Pageof 13